Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm
- PMID: 20074750
- DOI: 10.1016/j.jtcvs.2009.10.032
Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm
Abstract
Objective: Radiofrequency ablation for Barrett's esophagus in combination with an antireflux procedure has not been widely documented. We report our initial experience with radiofrequency ablation in association with antireflux procedure for Barrett's metaplasia and low-grade dysplasia.
Methods: A total of 14 patients (10 male and 4 female patients) presented with Barrett's metaplasia (n=11) or low-grade dysplasia (n=3). Median age was 60 years (38-80 years). The severity of Barrett's esophagus was classified by length (in centimeters), appearance (circumferential/noncircumferential), and histology (1, normal; 2, Barrett's metaplasia; and 3, low-grade dysplasia). Radiofrequency ablation was performed with the HALO 360 degrees or 90 degrees systems (BARRX Medical, Sunnyvale, Calif).
Results: Median follow-up was 17 months. The mean number of ablative procedures undertaken was 2.6 (range, 1-6). There was no mortality, but there were 2 perioperative complications after the antireflux procedure (pneumonia, 1; atrial fibrillation, 1). One patient had mild dysphagia requiring a single dilation 2 months after ablation. The mean length of Barrett's esophagus decreased from 6.2 to 1.2 cm after treatment (P=.001). Barrett's grade decreased significantly (P=.003). Before therapy, circumferential Barrett's esophagus was present in 13 patients. At last endoscopy, only 1 patient had circumferential Barrett's esophagus present. The number of radiofrequency ablation treatments was significantly (P < .05) associated with success. All patients receiving 3 or more treatments had complete resolution of Barrett's metaplasia.
Conclusions: Radiofrequency ablation performed either before or after an antireflux procedure is safe. This approach is effective for reducing or eliminating metaplasia and dysplasia. Long-term studies will be necessary to determine whether this approach can provide durable control of both reflux and Barrett's esophagus.
Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Similar articles
-
A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).Endoscopy. 2008 May;40(5):380-7. doi: 10.1055/s-2007-995587. Endoscopy. 2008. PMID: 18459074 Clinical Trial.
-
[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].Zentralbl Chir. 2004 Apr;129(2):99-103. doi: 10.1055/s-2004-816278. Zentralbl Chir. 2004. PMID: 15106039 German.
-
Radiofrequency ablation in Barrett's esophagus with dysplasia.N Engl J Med. 2009 May 28;360(22):2277-88. doi: 10.1056/NEJMoa0808145. N Engl J Med. 2009. PMID: 19474425 Clinical Trial.
-
Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.Expert Rev Med Devices. 2005 Nov;2(6):713-23. doi: 10.1586/17434440.2.6.713. Expert Rev Med Devices. 2005. PMID: 16293098 Review.
-
Gastroesophageal reflux disease and Barrett's esophagus.Endoscopy. 2005 Jan;37(1):8-18. doi: 10.1055/s-2004-826087. Endoscopy. 2005. PMID: 15657852 Review.
Cited by
-
The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.Dig Dis Sci. 2010 Jul;55(7):1918-31. doi: 10.1007/s10620-010-1218-1. Epub 2010 Apr 20. Dig Dis Sci. 2010. PMID: 20405211 Review.
-
FAILURE AFTER FUNDOPLICATION: RE-FUNDOPLICATION? IS THERE A ROOM FOR GASTRECTOMY? IN WHICH CLINICAL SCENARIES?Arq Bras Cir Dig. 2019 Aug 26;32(2):e1440. doi: 10.1590/0102-672020190001e1440. Arq Bras Cir Dig. 2019. PMID: 31460600 Free PMC article.
-
Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry.J Gastrointest Surg. 2013 Jan;17(1):21-8; discussion p.28-9. doi: 10.1007/s11605-012-2001-8. Epub 2012 Sep 11. J Gastrointest Surg. 2013. PMID: 22965650
-
Management strategies of Barrett's esophagus.World J Gastroenterol. 2012 Nov 21;18(43):6216-25. doi: 10.3748/wjg.v18.i43.6216. World J Gastroenterol. 2012. PMID: 23180941 Free PMC article. Review.
-
Low grade dysplasia in Barrett's esophagus: Should we worry?World J Gastrointest Pathophysiol. 2014 May 15;5(2):91-9. doi: 10.4291/wjgp.v5.i2.91. World J Gastrointest Pathophysiol. 2014. PMID: 24891980 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical